Protagonist Therapeutics' CEO on its hepcidin memetic at #ASH23 and oral IL23 program in I&I
Dinesh Patel describes the science behind Protagonist's polycythemia vera program and how the company is developing oral peptides, starting with IL23.
Also look for unique social pages for BiotechTV U.
At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.